两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-002007 Size: 5 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-002008 Size: 6 KB 网页链接
$Onconova医疗(ONTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-21-025842 Act: 34 Size: 44 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-001784 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-001785 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-001781 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-001782 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-21-001783 Size: 4 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-21-023945 Act: 34 Size: 30 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-21-020932 Act: 34 Size: 271 KB 网页链接